Delivery Order SPE2DB20D3303-SPE2DB25FA3RH
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,266.27 by the Defense Logistics Agency on August 12, 2025, for the supply of Betaseron 0.3 mg kits. This firm fixed-price delivery order, which carries an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The award is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $16,283.25 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order, awarded on August 1, 2025, represents a non-competitive award and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $28,856.00 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits. The contract is firm fixed price with no set-aside designation and was competitively awarded. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The work will be performed in Conshohocken,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a firm fixed price delivery order contract from the Defense Logistics Agency (DLA) Troop Support Medical valued at $14,734.37. The contract is for the delivery of 0.3 mg BETASERON medication kits, which are specialty pharmaceutical products used to treat certain medical conditions. This delivery order contract does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Betaseron 0.3 mg kits, a pharmaceutical product, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order has a ceiling value of $51,064.44 and an ultimate completion date of June 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This single-award IDC...
- This federal contract award, valued at $16,526.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Betaseron 0.3 mg kits, a specialty medication, with a completion date of December 22, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,153.78 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is fulfilling this order...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,944.37 firm fixed-price delivery order contract is for the supply of the drug BETASERON 0.3 MG KITS and has a performance period through June 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,432.45 delivery order contract is for the supply of BETASERON 0.3 MG KITS, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $18,798.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of BETASERON 0.3 MG KITS, a specialty medication. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price agreement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3RHDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on September 12, 2025, for the supply of Betaseron 0.3 mg kits valued at $16,778.88. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's pharmaceutical supply relationship with DLA, which procures medical supplies and pharmaceuticals for military and veteran healthcare systems across the Department of Defense. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a prime vendor under this IDC, the company supplies a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally. The Betaseron supply fulfills critical medication needs within the company's extensive portfolio of specialty medications, brand-name and generic drugs, and vaccines delivered to the Defense Health Agency and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.8k | 9/12/25 |